Skip to content

Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy (S-OPAT) — A prospective cohort study

Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy (S-OPAT) — A prospective cohort study - NOT-Pathogen

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021135
Enrollment
45
Registered
2020-04-23
Start date
2015-12-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T84.5

Interventions

Group 1: Treatment of multidrug-resistant pathogens resistant to all types of oral antibiotics by Outpatient Parenteral Antimicrobial Therapy (OPAT). As part of a multi-stage revision arthroplasty in

Sponsors

BG University Hospital Bergmannsheil
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criterion was the detection of a pathogen that could not be optimally treated with oral antibiotics according to the PRO-IMPLANT Foundation based on the management concept of Zimmerli et al. and adapted by Trampuz et al.

Exclusion criteria

Exclusion criteria: Patients with a mental disability or paraplegic symptoms are excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the successful infection eradication of multidrug-resistant (MDR) pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy (S-OPAT) in multi-stage revision arthroplasty. It is characterized by reimplantation of a prosthesis and completion of the antimicrobial therapy with an average duration time of 12 weeks. Patients are included in an ongoing follow-up to obtain data from long-term results, following the international consensus of successful PJI treatment by Diaz-Ledezma et al.

Secondary

MeasureTime frame
I) Evaluation of long-term outcome (10 years after the end of treatment) II) Assessment of complications related to APAT: 1) Adverse drug reactions (ADRs) 2) Catheter-related complications (CRC) Patients visited the hospital or their general practitioners at least once a week for follow-up clinical examination.

Countries

Germany

Contacts

Public ContactHinnerk Baecker

BG University Hospital Bergmannsheil

Hinnerk.Baecker@bergmannsheil.de0234 302 3008

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026